Massacesi; Cristian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Massacesi; Cristian.The latest application filed is for "combination for treating cancer".

Company Profile

4.4.20

Massacesi; Cristian - Summit NJ
Massacesi; Cristian - Neuilly Sur-Seine FR
MASSACESI; Cristian - Rueil Malmaison FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination for Treating Cancer App 20210386826 - Boshoff; Christoffel Hendrik ; et al.	2021-12-16
Combinations for Treating Cancer App 20210355223 - Boshoff; Christoffel Hendrik ; et al.	2021-11-18
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20210196696 - di Tomaso; Emmanuelle ; et al.	2021-07-01
Methods and Combination Therapy to Treat Cancer App 20210077463 - Boshoff; Christoffel Hendrik ; et al.	2021-03-18
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20200069670 - di Tomaso; Emmanuelle ; et al.	2020-03-05
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor Grant 10,434,092 - di Tomaso , et al. O	2019-10-08
Dosage Regimen For A Pi-3 Kinase Inhibitor App 20190134052 - HIRAWAT; Samit ; et al.	2019-05-09
Dosage regimen for a PI-3 kinase inhibitor Grant 10,213,432 - Hirawat , et al. Feb	2019-02-26
Pharmaceutical Combinations Comprising A Pi3k Inhibitor For The Treatment Of Cancer App 20180353495 - MASSACESI; Cristian ; et al.	2018-12-13
Dosage Regimen For A Phosphatidylinositol 3-kinase Inhibitor App 20180280370 - Schnell; Christian ; et al.	2018-10-04
Pharmaceutical combinations Grant 10,085,996 - Hirawat , et al. October 2, 2	2018-10-02
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20180078540 - di Tomaso; Emmanuelle ; et al.	2018-03-22
Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or prevention of a cancer of the head and neck Grant 9,913,846 - Hirawat , et al. March 13, 2	2018-03-13
Pharmaceutical Combinations App 20170304311 - Hirawat; Samit ; et al.	2017-10-26
Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck App 20170173032 - Hirawat; Samit ; et al.	2017-06-22
Pharmaceutical Combinations Comprising A Pi3k Inhibitor For The Treatment Of Cancer App 20170165246 - Massacesi; Cristian ; et al.	2017-06-15
Dosage Regimen For An Alpha-isoform Selective Phosphatidylinositol 3-kinase Inhibitor App 20170000778 - di Tomaso; Emmanuelle ; et al.	2017-01-05
Pharmaceutical Combinations App 20160331755 - Hirawat; Samit ; et al.	2016-11-17
Combination of a PI3 Kinase Inhibitor with Pacitaxel for Use in the Treatment or Prevention of a Cancer of the Head and Neck App 20160082012 - Hirawat; Samit ; et al.	2016-03-24
Dosage Regimen For A Pi-3 Kinase Inhibitor App 20150141426 - Hirawat; Samit ; et al.	2015-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.